Meso stock price target

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Mesoblast (MESO – Research Report) and Fate Therapeutics (FATE – Research Report) with bullish sentiments.Mesoblast (MESO) Maxim Group analyst Jason McCarthy maintained a Buy rating on Mesoblast today and set a price target of $16.00.The company’s shares closed last Monday at $8.00. Maxim Group Reaffirms Their Buy Rating on Mesoblast (MESO ... Mar 11, 2020 · In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on Mesoblast (MESO – Research Report), with a price target of $16.00.The company’s shares closed last Monday at $6.36. According to TipRanks.com, McCarthy ‘s ranking currently consits of no stars on a 0-5 ranking scale, with an average return of -6.0% and a 30.4% success rate. Mesoblast Ltd. ADR, MESO Quick Chart - (NAS) MESO ... Mesoblast stock price target cut to $5 from $10 at Credit Suisse MarketWatch. Monday, March 07, 2016. 07:42 AM ET. Mesoblast downgraded to neutral from overweight at J.P. Morgan MarketWatch. Wednesday, January 20, 2016. 08:19 AM ET. Mesoblast started at outperform with $10 stock price target at Credit Suisse MarketWatch. Monday, November 23 Where the Mesoblast Limited (MESO) stock Worth Stands, Do ...

MESO - Research and Analysis for MESOBLAST LIMITED - MSN ...

MESO Stock | MESOBLAST Stock Price Today | Markets Insider MESO: Get the latest Mesoblast stock price and detailed information including MESO news, historical charts and realtime prices. Its medicines target the cardiovascular diseases, spine MESO - Mesoblast Limited - Benzinga Jan 01, 2010 · Mesoblast is a small cap biotech company with listings on both the ASX and the Nasdaq. The company has acquired the rights to develop and … Analysts Offer Insights on Healthcare Companies: Mesoblast ...

MESOBLAST LIMITED : MESO Stock Price | MarketScreener

Mesoblast Price Target | MESO - Stock Screener, Excel ...